Quick Takeaways
- Harvey Partners, LLC filed SCHEDULE 13G/A for HARVARD BIOSCIENCE INC Common Stock, par value $0.01 per share (HBIO).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2025.
Harvey Partners, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for HARVARD BIOSCIENCE INC Common Stock, par value $0.01 per share (HBIO)
- Filing Manager
- Harvey Partners, LLC
- Reporting Manager
- HARVEY PARTNERS, LLC
- Symbol
- HBIO
- Shares outstanding
- 44,102,823 shares
- Disclosed Ownership
- 2,187,500 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:10:23 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Harvey Partners, LLC disclosed 5% ownership in HARVARD BIOSCIENCE INC Common Stock, par value $0.01 per share (HBIO) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 16:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HARVEY PARTNERS, LLC | 5% | 2,187,500 | 2,187,500 | 0 | /s/ Jeffrey C. Moskowitz | Jeffrey C. Moskowitz, Managing Member |